粘液真菌症
Dimitrios P Kontoyiannis1, Thomas J Walsh2,3,4
1Department of Infectious Diseases, Infection Control, and Employee Health, University of Texas M.D. Anderson Cancer Center, Houston.
The New England journal of medicine
|February 11, 2026
まとめ
粘液真菌症は、免疫不全者や糖尿病患者に影響を与える重度の真菌感染症です。この致死性の可能性のある病状において、死亡率を減らすためには、早期発見と治療(抗真菌療法や手術を含む)が不可欠です。
科学分野:
- mycology; Infectious Diseases; Immunology
背景:
- 粘液真菌症は、急速に進行する侵襲性の真菌感染症です。;重度の免疫不全患者、糖尿病患者、および外傷を負った免疫正常者に見られます。;この感染症は、鼻副鼻腔眼窩、鼻脳、鼻肺、胃腸、皮膚、播種性など、様々な形態で現れます。
研究 の 目的:
- 粘液真菌症の臨床症状と管理戦略の概説。;死亡率低下における早期発見と介入の重要性の強調。;現在および将来の治療アプローチの検討。
主な方法:
- 臨床像と診断アプローチのレビュー。;抗真菌療法や外科的介入を含む確立された治療プロトコルの議論。;患者転帰改善のための新たな研究領域の探求。
主要な成果:
- 早期介入(迅速な診断、抗真菌療法(リポソーム型アムホテリシンBが好ましい)、外科的切除、根本原因の管理を含む)は、粘液真菌症の死亡率を大幅に低下させます。;様々な臨床形態の粘液真菌症が存在し、それぞれに合わせた管理が必要です。;診断、新規抗真菌薬、免疫療法に関する進行中の研究は、有望視されています。
結論:
- 粘液真菌症は、集学的管理を必要とする生命を脅かす真菌症です。;生存率の向上には、適時かつ包括的な治療が不可欠です。;この破壊的な感染症と闘うためには、診断と治療法の進歩が極めて重要です。
関連する概念動画
Skin Diseases and Disorders
5.4K
Skin is the first line of defense and encounters a variety of microbes. Some pathogenic strains are often the cause of a broad range of infections of the skin and other body systems. These conditions can affect people of all ages and may have different causes, including genetic factors, infections, autoimmune reactions, environmental factors, and lifestyle choices.
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
5.4K
Fungal Group Zygomycota
2.1K
Zygomycota, previously classified as a distinct fungal group, are primarily terrestrial, saprophytic molds that play a crucial role as decomposers. Recent phylogenetic studies have revealed that these fungi are now divided into two major clades — Mucoromycota, which includes many symbiotic species, and Zoopagomycota, which primarily consists of parasitic and pathogenic fungi. These groups exhibit distinct ecological roles and reproductive strategies while sharing key structural and...
2.1K
Fungal Phylum Microsporidia
782
Microsporidia are a group of obligate intracellular fungi that were initially classified as protists but were later reclassified based on phylogenetic, molecular, and structural evidence linking them to the Chytridiomycota. These unicellular, non-motile organisms are highly specialized parasites that infect a wide range of animal hosts, including humans. They have evolved extensive genomic and metabolic reductions, making them highly dependent on their hosts for survival.Morphology and Genomic...
782
Fungal Phylum Ascomycota
2.4K
Phylum Ascomycota, a major division within the subkingdom Dikarya, comprises a diverse range of fungal species, including both unicellular yeasts and filamentous molds such as Aspergillus and Penicillium. These fungi thrive in a variety of habitats, from aquatic ecosystems to terrestrial environments, playing crucial ecological and economic roles.Morphology and ReproductionThe defining characteristic of Ascomycetes, commonly referred to as sac fungi, is the ascus—a sac-like structure that...
2.4K
Fungal Phylum Basidiomycota
2.1K
Basidiomycota is a diverse phylum of fungi that includes ecologically significant decomposers such as white rot fungi, symbionts like mycorrhizal fungi, plant pathogens such as rusts and smuts, and edible species like Agaricus bisporus (the common button mushroom). These fungi play crucial roles in nutrient cycling, symbiotic relationships, and even human health. Their defining feature is the basidium, a microscopic club-shaped structure responsible for producing basidiospores.Fruiting Bodies...
2.1K
Antifungal Agents
119
Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to...
119


